Press release 2009-09-28
C-RAD AB and its three fully owned subsidiaries are all active in the field of radiation therapy. The company attended and exhibited at the annual oncology meeting Jastro in Kyoto, Japan, 17-19 July. The C-RAD program was presented to oncologists from some of the most acknowledged centers in Japan. The annual oncology meeting Jastro in Japan is one of the major events in radiation therapy. This year's meeting was taking place in Kyoto, 17- 19 September. 1600 participants, mainly oncologists had applied for the meeting. Japan is the second largest market in radiation therapy with about 10% of the installed volume in radiation therapy. The Sentinel system was exhibited by the C-RAD representative Advanced Radiation Devices Inc. Three persons are at present working full time to promote the C-RAD program on the Japanese market. New leads were recorded for projects to be realized both in 2009/2010 and 2010/2011. Important meetings were also carried out with industrial partners. Erik Hedlund, CEO, C-RAD AB: "Japan is one of the most advanced markets in radiation therapy. Both clinicians and researchers are enthusiastic about the C-RAD surface scanning solution and the new GEMini technology. The C-RAD representative is optimistic to get first orders not later than March 2010." For further information: Erik Hedlund, CEO C-RAD AB, Telephone: +46- 18 - 66 69 31, E-Mail: erik.hedlund@c-rad.se